Price
CHART BY
Frequently asked questions
What is Intuitive's market capitalization?
The market capitalization of Intuitive is $186.83B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Intuitive's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Intuitive is 69.73. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Intuitive?
Intuitive's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $7.558. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Intuitive's stock?
Currently, 35 analysts cover Intuitive's stock, with a consensus target price of $603.81. Analyst ratings provide insights into the stock's expected performance.
What is Intuitive's revenue over the trailing twelve months?
Over the trailing twelve months, Intuitive reported a revenue of $9.61B.
How many employees does Intuitive have, and what sector and industry does it belong to?
Intuitive employs approximately 15,638 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Intuitive's shares?
The free float of Intuitive is 352.33M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $186.83B
- EPS (TTM)
- $7.558
- Free Float
- 352.33M
- P/E ratio (TTM)
- 69.73
- Revenue (TTM)
- $9.61B
Pricing
- 1D span
- $524.20$551.32
- 52W span
- $427.00$615.32
Analyst Ratings
The price target is $603.81 and the stock is covered by 35 analysts.
Buy
23
Hold
10
Sell
2
Information
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
- Employees
- 15,638
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- ISRG
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet